(Q33888684)

29 July 2017

1 reference

title

Prophylactic pharmacological treatment of chronic daily headache (English)

1 reference

29 July 2017

1 reference

1 reference

Redillas C

1

1 reference

29 July 2017

Solomon S

series ordinal

2

1 reference

29 July 2017

publication date

1 February 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

40

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

83-102

1 reference

Epidemiology of tension-type headache

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Classification of daily and near-daily headaches: proposed revisions to the IHS criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Transformed or evolutive migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Clinical diagnosis and computer analysis of headache symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Central and peripheral mechanisms in chronic tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Chronic tension headache--treated with amitriptyline--a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

TREATMENT OF CHRONIC TENSION HEADACHE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Protriptyline, chronic tension-type headaches, and weight loss in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Double-blind trial of fluoxetine: chronic daily headache and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Paroxetine in the treatment of chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Phenelzine therapy for headache patients with concomitant depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Possible mechanisms of valproate in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Intravenous magnesium sulfate rapidly alleviates headaches of various types

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Valproic acid treatment of chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Phantom eye: features and prevalence. The predisposing role of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Serotonin syndrome complicating migraine pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Focal cortical transient preceding myoclonus during lithium and tricyclic antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Early and transient side effects of repetitive intravenous dihydroergotamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

The use of methylergonovine (Methergine) in the initial control of drug induced refractory headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Headaches and face pains as a manifestation of Munchausen syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Repetitive intravenous dihydroergotamine as therapy for intractable migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Repetitive intravenous DHE in the treatment of refractory headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Lignocaine and headache: an electrophysiological study in the cat with supporting clinical observations in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-D-aspartate-mediated neuronal plasticity: their common clues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Transformed migraine, analgesic rebound, and other chronic daily headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

Clomipramine and Mianserin in the Treatment of Chronic Tension Headache. A Double-Blind, Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00014.X

10.1046/J.1526-4610.2000.00014.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference